IBS-C
Conditions
Interventions
experimental group:taVNS+PEG
control group 1:sham stimulation +PEG
control group 2:PEG
Sponsors
Department of Gastroenterology, The First Affiliated Hospital of USTC Anhui Provincial Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: (1) Patients who meet the diagnostic criteria for IBS-C; (2) Between the ages of 18 and 65, regardless of gender; (3) Voluntarily accept treatment with this drug and sign an informed consent form, which complies with the relevant provisions of GCP.
Exclusion criteria
Exclusion criteria: (1) Patients with serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney, and hematopoietic system diseases, hyperthyroidism, diabetes, or serious diseases (such as tumors) that affect their survival and mental patients; (2) Pregnant or preparing pregnant or lactating women; (3) Suspected or with a history of alcohol or drug abuse; (4) Individuals with cognitive impairment who cannot receive sufficient informed consent; (5) Patients who have participated in other clinical trials within the past month; (6) Patients who have undergone abdominal surgery within 6 months; (7) Individuals with general or special contraindications to physical therapy provided; (8) Researchers believe that there are patients with unsuitable factors for inclusion; (9) Patients who have been using various antibiotics and probiotics in the past month.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| IBS symptom; | — |
Secondary
| Measure | Time frame |
|---|---|
| manometry;autonomic nervous system; | — |
Countries
China
Contacts
Public ContactYue Yu
Anhui Provincial Hospital
Outcome results
None listed